SEPTIN6 and myelodysplastic syndrome: Subsequently, van Binsbergen et al [6] identified a second MLL-SEPT2 fusion variant in a patient with t-AML and we have recently uncovered a third MLL-SEPT2 alternative fusion variant in a case of therapy-related myelodysplastic syndrome (t-MDS) [7,8].